Iron Metabolism in Pathogenic Trypanosomes by Bruno Manta et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
6 
Iron Metabolism in Pathogenic Trypanosomes 
Bruno Manta, Luciana Fleitas and Marcelo Comini 
Group Redox Biology of Trypanosomes,  
Institut Pasteur de Montevideo, 
Uruguay 
1. Introduction  
1.1 Unique features, evolution and life cycle of trypanosomes 
Trypanosomatids comprise a large group of flagellated unicellular protists with free-living 
and parasitic lifestyles. Several members of this family are widely known for being 
vertebrate pathogens of biomedical and veterinary importance. They belong to the order 
Kinetoplastida, which together with the groups Diplonemida (deep-see organisms) and 
Euglenida (photosynthetizing organisms) form the phylum Euglenozoa (Simpson et al., 2006; 
Roger & Simpson, 2009). Kinetoplastids represent one of the most ancient eukaryotic 
lineages that diverged after the acquisition of the mitochondrion and share unique 
biochemical and subcellular features including the nuclear and mitochondrial gene 
expression mechanism, the energy and thiol redox metabolism and the organization of the 
mitochondrial DNA, named kinetoplast, and the compartmentalization of the almost entire 
glycolytic pathway in a peroxisome-like organelle called the glycosome. Phylogenetic 
studies support the theory that hemoflagellate trypanosomes evolved from a free-living 
bodonid that subsequently became an insect parasite, which later gained capacity to adapt 
to mammalian hosts (Adl et al., 2005, 2007; Hamilton et al., 2004; Simpson et al., 2002). An 
early split of the genus Leishmania from the trypanosome taxon together with the existence 
of two well-defined clades within the genus Trypanosoma (the “brucei” clade and the “cruzi” 
clade) are strong evidences that the different lineages of pathogenic trypanosomes have 
evolved independently. Although they share a common ancestor, trypanosomes from the 
“brucei” and “cruzi” clades evolved and are geographically confined to the African and New 
World (South-America and Oceania) continents, respectively. In contrast to members from 
the “cruzi” clade, several lines of evidence indicate that African trypanosomes co-evolved 
with their mammalian hosts and insect vectors (Hamilton et al., 2007; Maslov et al., 1996; 
Stevens et al., 1998; Stevens et al., 2001). Parasitic trypanosomes are naturally transmitted by 
arthropods, e.g. tsetse fly for T. brucei, kissing bug for T. cruzi, and sand fly for Leishmania 
spp. (Fig. 1). Occasionally, bats can also act as vector agents (Dávila & Silva, 2000) and, more 
recently, rats and ticks are discussed as potentially involved in transmission of T. cruzi and 
Leishmania parasites to mammals (Herrera & Urdaneta-Morales, 2001; Colombo et al, 2011; 
Dantas-Torres, 2011). The natural infectious cycle of these parasites is initiated when non-
dividing infective trypanosomes (metacyclic stage) are mechanically introduced in the 
mammal via insect bites or by involuntary deposition of infected feces from insects in the 
mucosa or injured dermis of mammals. Depending on the trypanosomatid species, parasites 
can reside in the host dermis (L. major), infect mucosa (L. brasilienzis and L. amazoniensis) or 
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internal tissues/organs (T. cruzi, L. donovani and L. infantum) or remain in the extracellular 
fluids (i. e., T. brucei ssp.). Inside the mammal hosts, parasites shuttle between proliferative 
and non-proliferative forms. Indeed, the non-proliferative stages play an important role in 
the perpetuation of the life cycle since they are pre-adapted to survive in the poikilothermic 
arthropod (Comini et al., 2011). They are taken up during insect blood meal of an infected 
host and further differentiate to dividing forms. The transformation to the quiescent 
infective stages occurs in the gut (T. cruzi) or salivary glands (T. brucei and Leishmania spp.) 
of the invertebrate. Trypanosomes undergo important metabolic and morphological 
changes to adapt to the growth conditions imposed by the different hosts and environments 
(extracellular medium and cell tissues) they inhabit. Fine tuning of energy metabolism, 
organelle reorganization and dedicated nutrient uptake are some of the mechanisms the 
parasite exploits to survive in the human host, as will be discussed below.  
Insect
vector
Mammals
Nagana
Leishmania spp.T. cruziT. brucei
Parasites
HAT
tse-tse fly
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sand-fly
 
Fig. 1. Life cycle and diseases caused by trypanosomatids. 
The genus Trypanosoma and Leishmania include species that are pathogenic for mammals. 
The natural cycle of these parasites involves their transmition by different but specific 
arthropods (insect vectors). Inside the host each species exhibit a peculiar tropism for 
different tissues, organs and systems resulting in different pathologies. For instance, T. 
brucei is an extracellar parasite that resides in the host´s bloodstream and cerebrospinal 
fluid; different strains of T. cruzi invade cardiomiocytes or nervous tissue from the digestive 
system; depending on the Leishmania species, the parasites invade the dermis, mucosa or 
internal organs (e. g., spleen). The diseases associated with infection are devastating and 
fatal if left untreated. Human pathogens from the ”brucei“ complex (T. b. rodhesiense and T. b. 
gambiense) cause sleeping sickness or human African trypanosomiasis (HAT; see section1); 
T. b. brucei produces nagana disease of cattle; T. cruzi is the ethiologic agent of Chagas 
disease in Latin-America; L. infantum and L. donovani produces visceral leishmaniasis, L. 
major and L. amazonensis causes cutaneous leishmaniasis, and L. brasiliensis is responsible for 
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a mucocutaneous infection. During their life cycle, the parasites undergo important 
biochemical and ultrastructural remodeling to adapt to the different hosts.The cycle is 
closed when insect feeds on infected mammals. 
1.2 Trypanosomiasis: Disease, burden and treatment 
Different members of the Trypanosomatida family are etiologic agents of highly disabling 
and often fatal diseases of humans and livestock (see Fig. 1). With respect to the parasites 
that are the major focus of this chapter, members from the T. brucei complex are transmitted 
by tsetse flies of the genus Glossina spp., which is found exclusively in equatorial Africa. The 
human pathogens T. b. gambiense and T. b. rodhesiense differ in their geographical 
distribution with the first subspecies being endemic of west and central regions while the 
last is mainly present in east and southern Africa (Barrett et al., 2003).  
HAT present two main clinical phases with compromise of the hematolymphatic system 
(acute phase) and the central nervous system (CNS, chronic phase). The T. b. rhodesiense 
infection develops rapidly as an acute disease that is characterized by a high parasite load, 
severe anemia and thrombocytopenia accompanied by hypertrophy of the 
reticuloendothelial system. If untreated, the pathology evolves to a pancarditis with 
congestive heart failure, pulmonary edema and physiological collapse (Barrett et al., 2003). 
Due to this fast and lethal development, along with the limited sanitary conditions of 
endemic regions, HAT caused by T. b. rhodesiense is usually under-diagnosed explaining - at 
least partly - why 90% of the reported cases of African sleeping sickness are ascribed to T. b. 
gambiense (Birkholtz et al., 2011). In contrast, HAT produced by T. b. gambiense displays a 
more discrete development without characteristic symptoms in the early phase, unless the 
patient develops a generalized lymphadenopathy, which hinders an accurate diagnosis. The 
second stage of HAT starts when the parasites invade internal organs, including the CNS. 
For T. b. rhodesiense and T. b. gambiense this phenomena can take place within few weeks and 
up to years upon infection, respectively. Invasion of the CNS by the parasite is typically 
accompanied by intense headache, sleeping disorders and mental dysfunction, leading to a 
comatose state and sudden death (Barrett et al., 2003). The differential pathogenicity and 
clinical manifestations of both diseases have been formerly explained on the basis of mutual 
host-parasite adaptations that shaped pathogen virulence and host resistance during 
evolution (Fèvre et al., 2006). However, the hypothesis of a co-evolutionary virulence 
attenuation of T. b. gambiense has recently been challenged by studies on phylogenetic 
relationships within the T. brucei taxon (Balmer et al., 2011).  
The World Health Organization (WHO) estimates that sixty million people are at risk of 
infection as a consequence of at least 300 separate active foci in 36 African countries (Jacobs 
et al., 2011), most of them in rural areas of extreme poverty. Around 300,000 people are 
currently infected with trypanosomes and 48,000 of them dye per year (Cavalli & Bolognesi, 
2009). The lack of local human and financial resources combined with the burden of conflicts 
in most of the endemic countries impedes to achieve full control of HAT (Cavalli & Bolognesi, 
2009). However, after continued control programs spanning vector eradication, early diagnosis 
and treatment, and surveillance (Barrett et al., 2003; Cavalli, 2009) the number of annual 
infections fell almost 5- to 7-fold in the last three decades1. Unfortunately, this progress is not 
                                                                 
1 http://www.who.int/mediacentre/factsheets/fs259/en/ 
www.intechopen.com
 
Iron Metabolism 
 
150 
accompanied by the development of new chemotherapeutic options (see below) and is 
endangered by the increasing drug resistance of the naturally circulating strains of T. brucei 
ssp. (Cavalli & Bolognesi, 2009; Delespaux  & de Koning, 2007; Jacobs et al., 2011; Matovu et al., 
2001). In addition to HAT, animal trypanosomiasis represents a major problem for the 
agricultural and nutritional development of endemic regions. About ten million square 
kilometers of arable land are infested by tsetse flies (Matovu et al., 2001) capable of 
transmitting T. b. brucei, T. congolense and T. vivax (Nagana-disease) or T. evansi (Surra-disease) 
between domestic and wild (reservoirs) animals. For Africa, the total economic losses due to 
animal trypanosomiasis are estimated to be US$ 4.75 billion per year2. The recent detection of 
members from the “brucei” clade in countries from Asia, Central- and South-America should 
raise alarm considering the serious threat these pathogens entails for the well-developed 
agricultural economies of these regions (Luckins & Dwinger, 2004; Batista et al., 2007, 2009; Da 
Silva et al., 2011; Dávila & Silva, 2000; Mekata et al., 2009).  
Confronted with the lack of prospect for vaccine development against trypanosomiasis, 
chemotherapy remains as the only short- and mid-term therapeutic choice for these 
diseases. Nevertheless, the few drugs currently available against HAT (acute phase: 
pentamidine and suramine, chronic phase: melarsoprol and efluornithine3) are far from 
optimal: most of them were originally developed for veterinary use, lacking safety 
compliance, and present a limited efficacy against late-stage disease (Steverding, 2010). An 
additional drawback associated with the inappropriate use of these drugs lies on the 
emergence of resistance. Unfortunately, pharmaceutical companies are less prone to engage 
and invest in drug discovery and development against diseases that affect the world´s 
poorest people (Barrett et al., 2003; Cavalli & Bolognesi, 2009; Matovu et al., 2001). However, 
in the last years, scientists, policy-makers and non-profit institutions (WHO, TDR, Médecins 
Sans Frontieres, FioCruz Institute, Drugs for Neglected Disease initiative), together with a 
few pharmaceutical companies (Glaxo SmithKline®, Bayer®), have joined efforts to improve 
this situation. As mentioned above, trypanosomes present several unique biochemical and 
biological features that can be exploited for the development of specific therapies. These 
include several organelles (glycosomes, acidocalcisomes, kinetoplast) that are absent in the 
mammalian host, and metabolic pathways and cellular functions that differ significantly 
from host counterparts, namely carbohydrate metabolism, protein and lipid modification, 
thiol-redox metabolism, cell cycle, programmed cell death, etc. (Naula & Burchmore, 2003). 
Despite the obvious indispensability of iron for pathogenic trypanosomatids, the 
mechanisms and components comprising the uptake, storage and usage of this metal have 
been poorly investigated. In the next sections will be reviewed the state-of-the-art regarding 
iron-homeostasis and metabolism in African trypanosomes. 
2. Iron acquisition and homeostasis  
Owing the extracellular and parasitic lifestyle of African trypanosomes, it deems important 
to comment first on the mechanisms and components controlling iron homeostasis in the 
human host. Dietary ferric iron (Fe3+) is reduced to its ferrous form (Fe2+) by a ferrireductase 
                                                                 
2 Amounts in terms of agricultural Gross Domestic Product, data taken from:  
http://www.fao.org/ag/againfo/programmes/en/paat/disease.html 
3 It must be noted that efluornithine is active only against T. b. gambiense but not T. b. rodhesiense 
(Cavalli & Bolognesi, 2009; Jacobs et al., 2011; Matovu et al., 2001). 
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present in the membrane of enterocytes, and then incorporated via a divalent metal 
transporter. Cytosolic iron is exported to the circulation from the basolateral membrane of 
enterocytes through ferroportin with the concomitant reoxidation to Fe3+ by the multicopper 
oxidase hephaestin (Kosman, 2010). Iron circulates in plasma bound to the glycoprotein 
transferrin (Tf), which is internalized by cells via a specific transferrin receptor (TfR1) in a 
clathrin-dependent mechanism. In the acidic environment of the endosome Tf, iron and 
TfR1 disassemble. Apo-Tf is released to circulation whereas TfR1 is recycled back to the 
membrane. Fe3+ is exported from the late endosomal vesicle through the concerted action of 
transporters and metalloreductases (Hentze et al., 2010; Kurz et al., 2011). How this “labile 
iron pool” (LIP, Hider & Kong, 2011; Kakhlon & Cabantchik, 2002) is trafficked within the 
cell remains poorly understood (Hentze et al., 2010; Anderson & Vulpe, 2009; Atanasiu et al., 
2007; Hentze et al., 2010; Subramanian et al., 2011). Other major source of iron comprises the 
recycling of heme-iron from senescent erythrocytes, a task carried out by specialized 
macrophages of the reticuloendothelial system known as Kupffer cells (Anderson & Vulpe, 
2009; Schultz et al., 2010). The liver is both the major site for iron storage and also the central 
metabolic regulator. Induced by different stimuli –from iron availability to inflammatory 
stresses– (Zhang & Enns, 2009), hepatocytes produce and secrete a 25-aminoacid hormone, 
hepcidin (Atanasiu et al., 2007), which regulates the levels of systemic iron by a negative-
loop mechanism that involves ferroportin turnover. Intracellular iron homeostasis is 
regulated post-transcriptionally by the iron regulatory protein 1 (IRP1, see section 3.3.3.1). 
The vast majority of iron is dedicated to hemoglobin or myglobin synthesis, but also the 
biogenesis of iron-sulfur (Fe/S) proteins demands this metal. Both processes occur mostly in 
the mitochondria, representing the main subcellular compartment for iron utilization (Levi 
& Rovida, 2009). Iron is stored bound to ferritin heteropolymers, which can hold up to 4500 
Fe3+ atoms (Andrews, 2010). Heme-iron is also essential in mammalian physiology (see 
section 4) but it poses an independent mechanism of absorption that remains mostly 
unsolved (Schultz et al., 2010). As envisaged, iron homeostasis is tightly controlled at several 
levels -from absorption to mobilization and utilization- and in an interdependent manner in 
humans.  
Iron is an essential element also for T. brucei, therefore the parasite has developed 
exceptional mechanisms to guarantee metal supply from a host that (un)intentionally limits 
metal availability in response to infection (see section 5). For example, iron-deficiency 
induced by ferritin upregulation and reduction of iron-transferrin saturation is a classical 
immune-based response mounted during the acute phase of the infection to limit parasite 
proliferation (Chisi et al., 2004). Also the chronic stage is accompanied by a notorious iron 
deprivation (e.g. anemia, see section 5) but, in this case, its origin is a chronic inflammatory 
disorder involving macrophage hyperactivation along with iron accumulation within the 
reticuloendothelial system (Stijlemans et al., 2008). In the bloodstream, trypanosomes 
acquire the metal4 via a high affinity receptor-mediated endocytosis of iron-loaded Tf (see 
Fig. 2; Grab et al., 1992, 1993; Steverding et al., 1995). The trypanosomal Tf receptor (TfR) was 
identified as a heterodimeric complex of proteins encoded by the expression-site-associated-
gene (ESAG) 6 and ESAG 7 (Salmon et al., 1994; Steverding et al., 1995). ESAG 6 and 7 are 
truncated forms of variable surface glycoproteins (VSG) that lack the C-terminal domain, and, 
in the case of ESAG 7, the glycophosphatidylinositol (GPI) anchor. Under normal growth 
                                                                 
4 The incorporation of heme-bound iron is discussed in section 4.  
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Fig. 2. Working model for iron acquisition and utilization in Trypanosoma brucei.  
Iron is incorporated from the host bloodstream through receptor (TfR) mediated 
internalization of loaded transferrin (Tf, upper left) at the flagellar pocket. In the late 
endosomes, Tf is degraded by a cathepsin B-like protease (CatB) and iron is released to the 
cytosol through the concerted action of a ferric reductase (Fe-RED) and a divalent cation 
transporter (DCT). Once in the cytosol iron is complexed to low molecular mass ligands 
forming the labile iron pool (LIP, see section 2) that probably fuels the synthesis of iron-
dependent enzymes like the glycosomal superoxide dismutase (gFe-SOD) or ribonucleotide 
reductase (RNR), and the biogenesis of cytosolic Fe/S clusters (CIA system, section 3.3.1). 
Mitochondrial Fe/S cluster biogenesis depends on iron imported in a membrane-potential 
dependent (mp) fashion at expenses of the inner membrane carriers Mrs3/4. Mitochondrial 
iron is either incorporated to iron-centered enzymes (e.g. Fe-SOD and trypanosomal 
alternative oxidase, TAO) or participates in Fe/S cluster biogenesis (ISC system, see section 
3.3.1.2). Black letters refer to proteins that have been reported in T. brucei and red letters 
denote components of the iron- and Fe/S cluster metabolism not yet identified in 
trypanosomes but with essential functions in yeast or mammals. CIA proteins are depicted 
in green tones, ISC proteins in orange-brown tones, membrane transporters in purple and Fe 
or Fe/S cluster receiving proteins in grey. Fe and sulfur atoms are shown as red and yellow 
spheres, respectively. Scheme based in Lill & Mühlenhoff, 2008; Hentze et al., 2010 and 
Taylor & Kelly, 2010. 
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conditions the TfR localizes at the flagellar pocket wherefrom bound-transferrin is internalized 
and proteolyticaly degraded in the endolysosome by a cathepsin-B like protease (O’Brien et al., 
2008; Mussmann et al., 2003), which finally releases iron. The relevance of the endocytic 
pathway as the sole source of iron for the parasite was demonstrated using antibodies anti-TfR 
that inhibited growth of T. brucei in vitro (Grab et al., 1992). Expression of TfR in the parasite is 
regulated by iron availability and post-transcriptional control that does not involve the 
IRE/IRP1 system typical for mammals (Fast et al., 1999). Iron starvation induced by iron 
chelators or species-specific transferrins lead to a 3- to 10-fold upregulation in the expression of 
TfR with a concomitant redistribution of the receptor from the flagellar pocket to the entire 
parasite surface (Fast et al., 1999; Mussmann et al., 2004). This, together with the rapid recycling 
of TfR (Kabiri & Steverding, 2000) and gene-specific (in)activation events (van Luenen et al., 
2004) allows trypanosomes to efficiently compete for limiting substrate and withstand iron-
deprivation until a new set of higher affinity TfR is expressed. For instance, sequence 
polymorphisms in ESAG 6 and 7 were proposed to determine the affinities of TfR for 
transferrins from different mammalian species (Bitter et al., 1998) permitting for a rapid 
adaptation of the parasite to distinct hosts. It was also suggested that the TfR repertoire may 
allow the parasite to overcome anti-TfR antibody response by the host (Gerrits et al., 2002). 
However, estimations and studies by Steverding (1998, 2003, 2006) disproved this hypothesis 
and supported the view that high affinity TfRs were evolutionary selected to enable the 
parasite to cope with the diversity of mammalian transferrins (Steverding, 2003, 2006).  
In the aerobic and buffered milieu of the cytosol iron is never free, mostly because it can 
readily produce highly toxic oxygen species through Fenton chemistry (see section 3.2.2), 
but also because the ferric form tends to form insoluble hydroxides. The cellular labile or 
chelatable iron pool is defined as the intracellular pool of redox-active iron that is not 
associated with proteins. LIP comprises ~ 5 % of the total cellular iron and consist of Fe2+ 
and Fe3+ associated with a diverse population of low molecular mass ligands such as organic 
anions (phosphate, citrate, inositol phosphate, etc.), polypeptides such as glutathione (GSH) 
and/or components of membranes (phospholipids, etc; Kakhlon & Cabantchik, 2002). 
Whether this percentage represents the situation in trypanosomes is unknown. The nature 
of the ligand(s) can vary between cells and among different physiological states but recent 
reports support the notion that intracellular GSH (2-5 mM) is the most relevant low 
molecular mass complexing agent in most GSH-dependent organisms (Hider & Kong, 2011; 
Kumar et al., 2011; Mühlenhoff et al., 2010; Overath et al., 1986). The nature of this LIP in 
trypanosomes was never assessed and it is worthy to speculate that trypanothione (T(SH)2, 
see below), and not GSH, will be the relevant physiological ligand. Beyond that T(SH)2 is the 
most abundant intracellular low molecular mass thiol in trypanosomes (Krauth-Siegel & 
Comini, 2008), our working model is supported by experimental evidences showing the 
formation of T(SH)2-Fe and T(SH)2-Fe/S complexes in vitro (Ceylan et al. 2010; Manta et al., 
unpublished, Fig. 2) and by the extensive documentation showing that most thiol-
dependent functions in these organisms evolved to use T(SH)2 and not GSH as cofactor 
(reviewed in Irigoín et al., 2008; Krauth-Siegel and Comini, 2008). How iron enters and exits 
the LIP and which are the proteins involved in this process remain as open questions. 
Recent studies propose a link between the LIP and Fe/S protein metabolism by means of a 
mechanism that involves Fe/S clusters as signalling molecule and cytosolic monothiol 
glutaredoxins as mediators (see section 3.2.1; Kumar et al., 2011; Mühlenhoff et al., 2010). In 
fact, the nature of monothiol glutaredoxins (i.e. iron-sulfur proteins that use GSH as ligand 
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cofactor for Fe/S cluster assembly) make these proteins exceptional candidates for the 
integration of the cellular iron and Fe/S cluster status with thiol redox status, and as signal 
transducer regulating iron uptake and utilization (Mühlenhoff et al., 2010; Rodriguez-
Manzaneque et al., 2002; Rouhier et al., 2010; Ye et al., 2010). Another important form of 
“low-molecular mass” iron species are the dinitrosyl iron complexes (DNIC, Bosworth et al., 
2009) formed between LIP and low molecular mass thiols when nitric oxide is present 
(Vanin, 2009). This point is addressed in the next section.  
3. Cellular fates of Iron 
Iron is an important redox or structural cofactor of several indispensable proteins of 
trypanosomes. For instance, DNA synthesis, protein translation, oxidant defense and 
cytochrome respiration are important cellular functions that involve the utilization of this 
metal (Taylor & Kelly, 2010).  
In this section we will review the most relevant iron-related molecules and metabolic 
pathways of bloodstream T. brucei. Whenever possible, the components and mechanisms 
employed by the parasite to incorporate different forms of iron onto target molecules will be 
described. Taking advantage of the recent availability of genome sequencing data for the 
most representative species of Trypanosoma (Berriman et al., 2005; El-Sayed et al., 2005; Ivens 
et al., 2005) and the current knowledge of the iron metabolism in model eukaryotes (Hentze 
et al., 2010), we here provide a state-of-the-art view of iron metabolism in African 
trypanosomes.  
3.1 Dinitrosyl iron complexes 
Parasites circulating in host´s bloodstream or inside the phagolysosome of activated 
macrophages are exposed to reactive oxygen and nitrogen species. In both cases, the second 
messenger nitric oxide (NO) is produced by endothelial or immune cells, which, if not 
neutralized rapidly, can lead to the formation of the highly reactive oxidant peroxynitrite 
(Girard et al., 2005). The effect of NO and derivatives was studied in T. brucei (Lu et al., 
2011; Steverding et al., 2009; Vincendeau et al., 1992) and T. cruzi (Piacenza et al., 2007; 
Alvarez et al., 2011  and see papers quoted in Irigoín et al., 2008). A recent work by Bocedi et 
al. (2010) demonstrated the formation in vitro of a DNIC involving the parasite specific 
dithiol T(SH)2. Based on the high intracellular concentration of T(SH)2 the authors proposed 
that formation of this complex may play an important role in trapping NO and, thus, 
preventing the formation of dangerous oxidants. This work raises the possibility for a new 
potential link between iron and low-molecular mass thiols in trypanosomes. 
3.2 Mononuclear iron proteins  
Mononuclear iron proteins can be classified according to their biological function, by Fe centre 
type, by type and number of prosthetic centres, and by sequence similarity. The iron atom is 
usually coordinated by thiolate groups (deprotonated form of cysteine), or the Nǅ atoms of 
histidines or the carboxylate anions of acidic residues present in the polypeptide. In these 
proteins the iron provides redox activity and the surrounding aminoacidic and structural 
environment confer the specificity for different substrates. The characteristics and functions of 
a number of iron-centered proteins from trypanosomatids are addressed below.  
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3.2.1 Energy metabolism: Alternative oxidase 
The bloodstream form of the parasite lacks cytochrome activity yet they “respirate” at high 
rates (Priest & Hajduk, 1994). The molecular entity responsible for this is a plant-like 
mitochondrial ubiquinol oxidase (EC 1.10.3.10), known as trypanosomal alternative oxidase 
(TAO; Clarkson et al., 1989). The enzyme is imported into the mitochondrion of bloodstream 
and procyclic parasites by distinct mechanisms involving external ATP supply and inner 
membrane potential, respectively (Williams et al., 2008). It localizes at the outer membrane 
of the organelle where it transfers electrons from ubiquinol to oxygen without proton 
translocation or ATP generation (Chaudhuri et al., 2006), resulting in the reoxidation of 
NADPH produced during glycolysis. TAO genes have been identified in the genome of all 
the subspecies forming the “brucei” clade but are absent in related trypanosomatids such as 
Leishmania spp. or T. cruzi (Chaudhuri et al., 2006; Nakamura et al., 2010). In agreement with 
its metabolic function (NADP/NAPDH-shunt during carbohydrate catabolism), TAO is 
developmentally regulated (Chaudhuri et al., 2002) achieving ~100 times higher levels in 
bloodstream parasites than in procyclic cells (Tsuda et al., 2005; Tyler et al., 1997). The 
essential role of TAO in the physiology of infective T. brucei was recognized early using the 
iron chelator salicyl hydroxamic acid (2-hydroxybenzhydroxamic acid, SHAM) and glycerol 
to alter the metabolic output (Clarkson & Brohn, 1976; Grant & Sargent, 1960). On the other 
hand, recent studies show that TAO plays an important role in preventing oxidant-induced 
programmed cell death of long-slender bloodstream parasites (Tsuda et al., 2005, 2006). This 
antioxidant function of TAO resembles that proposed for the orthologue enzyme from plants 
(Maxwell et al., 1999). In trypanosomes, apoptosis is a highly regulated process deeply 
associated with the accumulation of quiescent parasite forms (short stumpy) in the preparation 
for transmission to the insect vector (Welburn et al., 2006). It is therefore tempting to speculate 
that, at least in bloodstream trypanosomes, TAO might be an important checkpoint connecting 
metabolic status (NADP+/NAPDH ratio) with programmed cell death and differentiation. In 
procyclic forms, TAO has been shown to compensate for a depletion of complex III or IV 
activities in the mitochondrial electron transfer chain (Horváth et al., 2005). Despite this backup 
role in respiration, the enzyme appears to fulfill a yet unknown but essential function in this 
parasite stage (Tsuda et al., 2005; Tyler et al., 1997).  
Although no structures are available for TAO or any other related alternative oxidase, 
current structural models (Moore & Albury, 2008) and proteomic data (Acestor et al., 2009) 
indicate that it is an interfacial membrane protein that interacts with a single leaflet of the 
lipid bilayer, and contains a non-heme di-iron carboxylate center bounded by two highly 
conserved EXXH motifs (Kido et al., 2010a, 2010b). The iron-dependence of TAO was 
established working in vitro with chelating agents and mutant forms of the protein (Ajayi et 
al., 2002; Chaudhuri et al., 1998).  
3.2.2 Oxidant defense: Iron-dependent superoxide dismutases  
Aerobic respiration produce partly reduced oxygen intermediates that leak from several 
protein complexes from the electron transport chain. The most important radical species 
formed is the anion superoxide (O2-), the one-electron reduction product of molecular 
oxygen. Superoxide can reduce or oxidize biological targets in vivo, or dismutate to the less 
reactive but highly diffusible oxidant hydrogen peroxide (Halliwel & Gutteridge, 1999). 
Despite hydrogen peroxide is biologically more toxic than O2-, active removal of this anion 
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radical is necessary to prevent formation of the most reactive and harmful radical product, 
hydroxyl radical (OH), which originates from a physiological reaction involving iron and 
known as Fenton reaction5. To accomplish this, all living organisms contain enzymes 
devoted to the O2- dismutation, called superoxide dismutases (EC 1.15.1.1). There are three 
major families of SODs, depending on the metal cofactor. Most of the cytosolic eukaryotic 
SODs use a bimetallic active site with copper and zinc (CuZn-SODs) while the mitochondria 
harbor a bacterial-related Mg-dependent SOD. In prokaryotes and plastids most of the SODs 
are Fe-dependent (Abreu & Cabelli, 2010).  
Trypanosomes express four different isoforms of SODs (Dufernez et al., 2006; Kabiri & 
Steverding, 2001; Le Trant et al., 1983; Wilkinson et al., 2006) that, in contrast to homologues 
from prokaryotes and eukaryotes, show a restricted metal dependency all of them being Fe-
dependent enzymes (Wilkinson et al., 2006; Bachega et al., 2009). In T. brucei, SOD-A and 
SOD-C localize at the mitochondrion whereas SOD-B1 and SOD-B2 are mostly 
compartmentalized within the glycosome and less abundantly at the cytosol (Dufernez at 
al., 2006). A similar localization was reported for SOD-B enzymes from L. chagasi (Plewes et 
al., 2003). RNAi-mediated knockdown of SOD-A and SOD-C revealed that under normal 
growth conditions the mitochondrial isoforms are dispensable for bloodstream T. brucei 
(Prathalingham et al., 2007; Wilkinson et al., 2006). However, the biological importance of 
SOD-A was put in evidence when parasites depleted in this isoform showed a higher 
sensitivity towards paraquat, an O2--generating compound (Wilkinson et al., 2006). 
Consistent with a role in oxidant defense for mitochondrial Fe-SOD, transgenic T. cruzi 
overexpressing a mitochondrial isoform was found to be more resistant to fresh human 
serum, a death stimuli mediated by oxidative stress (Piacenza et al., 2007). In contrast, the 
SOD B-type enzymes are indispensable for infective T. brucei grown under normal culture 
conditions (Wilkinson et al., 2006), which poses the question to the glycosomal source of O2-
, a charged molecule that does not diffuse through lipid membranes. In this respect, 
unwanted O2- might leak as byproduct from a variety of metabolic activities occurring in 
this organelle, such as glycolysis, oxidation of fatty acids, lipid biosynthesis, and purine 
salvage (Michels et al., 2006). Further dissection of the functional relevance of SOD-B 
isoforms was achieved by means of targeted gene replacement, which demonstrates that 
SOD-B1 and not SOD-B2 is critical to withstand exposure to nifurtimox and benznidazole 
(Prathalingham et al., 2007), two anti-trypanosomal drugs whose mechanism of action 
involves the generation of reactive oxygen intermediates (Maya et al., 2003 and 2007). Also 
the homologue isoforms present in L. chagasi and L. tropica were earlier reported to be 
important for parasite survival in mouse or human macrophages as well as under paraquat 
insult (Plewes et al., 2003; Ghosh et al., 2003). Interestingly, T. brucei SOD-B1 has been shown 
to be developmentally regulated with higher intracellular concentration in proliferating 
stages (Kabiri & Steverding, 2001). This particular expression pattern led the authors to 
propose that the role of SOD-B1 in dividing cells is to counteract the formation of 
superoxide radicals released during the generation of the iron-tyrosyl free-radical centre in 
the small subunit (R2) of ribonucleotide reductase, other iron-containing enzyme (see next 
section). Unexpectedly, a 5- to 8-fold increase in SOD-B1 activity in transgenic T. cruzi was 
accompanied by a significant sensitization of parasites against two pro-oxidant compounds 
namely gentian violet and benznidazole (Temperton et al., 1998). This striking behavior was 
                                                                 
5 H2O2 + O2●- OH- + OH● + O2 Fe3
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interpreted as a consequence of an imbalance in the redox homeostasis of the parasite resulting 
from the overexpression of Fe-SOD, a hypothesis that deserves further investigation.  
In summary, trypanosomal SODs diverged from their human homologues by using iron as 
cofactor. They apparently evolved to protect parasites against toxic O2- produced in the 
glycosomes and/or mitochondrion as a result of sudden changes in metabolism or 
originated from the different environment they live in (e.g., insect midgut, macrophages, 
epithelium, mammal bloodstream).  
3.2.3 Cell proliferation: Ribonucleotide reductase 
Ribonucleotide reductase (RNR, EC 1.17.4.1-2) catalyses the reduction of ribonucleotides to 
deoxyribonucleotides needed for DNA synthesis. There are three different classes of RNR 
being class I the most abundant in eukaryote organisms. Class I RNR are heterotetrameric 
enzymes formed by the association of two related but not identical polypeptides known as 
subunit R1 and R2. The large R1 subunit binds substrates and allosteric effectors, conferring 
specificity and regulatory potential, while the small R2 subunit contains the catalytic center 
composed of two high spin Fe3+ atoms antiferromagnetically coupled to each other through 
a µ-oxo bridge, a highly conserved tyrosine residue and two cysteines (Cotruvo & Stubbe, 
2011). The di-iron center generates a free radical on this catalytic tyrosine through electron 
donation. In a reaction involving several intermediate states, the tyrosine radical attacks the 
nucleotide resulting in reduction of the 2’-OH group of ribonucleoside and the formation of 
a disulfide. Regeneration of active RNR is finally achieved via reduction of this disulfide 
mainly by thioredoxin (Trx), which is subsequently reduced at expenses of NADPH 
(Cotruvo & Stubbe, 2011).  
The biochemical information about parasite RNR is rather limited. Both subunits of RNR 
from T. brucei were cloned, expressed (Dormeyer et al., 1997; Hofer et al., 1997) and 
kinetically characterized (Hofer el al., 1998). The parasite-specific thioredoxin-like 
oxidoreductase tryparedoxin (TXN, Lüdemann et al., 1998) and, in contrast to all other 
RNR from eukaryotes, also the low-molecular weight dithiol T(SH)2 (Dormeyer et al., 
2001) but less likely glutaredoxins (Ceylan et al., 2010) proved to be physiological 
reductants of recombinant RNR. The activity of the enzyme appears to be post-
transcriptionally regulated by a redox mechanism (Dormeyer et al., 2001) and by the 
selective expression of its catalytic subunit R2. For example, whereas the R1 protein is 
actively expressed throughout the whole life cycle of the parasite, the R2 protein is not 
detected in cell cycle-arrested short stumpy trypanosomes (Breidbach et al., 2000). How 
iron is incorporated into the R2 subunit is yet elusive (Cotruvo & Stubbe, 2011). Recent 
findings suggest that, at least in yeast, the di-iron non-heme incorporation into apo-
proteins is tightly related to the Fe/S cluster biogenesis machinery both from the cytosol 
and mitochondria (see section 3.3) (Cotruvo & Stubbe, 2011; Mühlenhoff et al., 2010) and 
in particular to the cytosolic monothiol glutaredoxins (Grx3/4), discussed later in this 
review (see section 3.3.2). In trypanosomes, the only link between iron and RNR came 
from experiments in which parasites treated with the iron chelator deferoxamine (DFX) 
show an extremely reduced [3H]-timidine incorporation, pointing to an essential role of 
iron in DNA synthesis (Breidbach et al., 2002).  
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3.2.4 Lipid biosynthesis: Stearoyl-CoA desaturase 
Stearoyl-CoA desaturases (SCD) from eukaryotes are di-iron containing proteins responsible 
for the de novo synthesis of monounsaturated fatty acids from saturated fatty acids. The iron 
is usually coordinated by 8 histidine residues that form the active site (Man et al., 2006). 
They are integral membrane proteins anchored in the endoplasmic reticulum. Recent genetic 
and chemical validation of the orthologue enzyme from T. brucei demonstrated its 
indispensability for in vivo survival of bloodstream forms, as well as for the procyclic stage 
(Alloati et al., 2010, 2011). 
3.3 Iron-sulfur cluster proteins
6
 
The name iron-sulfur proteins refer to a broad group of proteins. A class of them contains 
mononuclear Fe centers coordinated directly by cysteine residues (e. g., rubredoxins and 
related proteins). A second class ligates a complex between iron and inorganic sulfur 
through side-chain atoms provided mainly by the aminoacid cysteine, or eventually 
histidine or aspartate. These centers are known as Fe/S clusters (Lill & Mühlenhoff, 2008). 
Fe/S centers are ubiquitous inorganic cofactors present in all forms of life and are probably 
the most ancient cofactors and catalysts in the prebiotic world. Among them, the [2Fe-2S] is 
the simplest and most common cluster found in vivo, whereas Fe/S clusters of higher 
complexity require further “maturation” (Lill & Mühlenhoff, 2008; Lill, 2009; Py & Barras, 
2010). In eukaryotes, the list of Fe/S dependent proteins has nearly one hundred members 
(Rouault & Tong, 2005; Ye & Rouault, 2010). In general, this cofactor enables electron 
transfer reactions due to the propensity of the iron atoms to switch between reduced (Fe2+) 
and oxidized (Fe3+) states. In addition, the redox potential of the cluster can be finely tuned 
by the protein environment covering a wide range of potentials, from very reducing (~-500 
mV) to highly oxidizing (~+300 mV) (Lill, 2009; Xu & Møller, 2011). In consequence, Fe/S 
clusters are essential components of the most important biological electron transport chains, 
i.e. photosynthesis and mitochondrial respiration. But the role Fe/S clusters can play in 
proteins goes far beyond their redox properties. For instance, they act as important 
structural or regulatory moieties of some proteins from the DNA metabolism and as 
cofactors in enzymes of the amino acid biosynthesis or Krebs cycle (Lill & Mühlenhoff, 2006; 
Lill, 2009; Netz et al., 2010; Py & Barras, 2010; Ye & Rouault, 2010a, 2010b). 
3.3.1 Biogenesis of iron-sulfur clusters and proteins 
Despite the chemical simplicity of these cofactors, their biosynthesis and insertion into 
apoproteins within the cell requires devoted machineries that are are highly conserved from 
bacteria to humans (Lill & Mühlenhoff, 2006, 2008; Xu & Møller, 2011). In bacteria, there are 
three different systems for the biogenesis of Fe/S proteins, all encoded in specific operons 
and tightly regulated. The “nitrogen fixation” (NIF) system was the first Fe/S cluster 
biogenesis mechanism described and is exclusively dedicated to the maturation of 
nitrogenase enzymes from certain bacterias. On the contrary, the “iron-sulfur cluster” (ISC) 
                                                                 
6 Due to the high amount of literature on this topic, this section contains mainly quotations to the most 
recent reviews, facilitating further reading for interested lectors. We therefore apologize to the authors 
of the original contributions. 
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and “sulfur utilization factor” (SUF) systems are widely distributed among bacteria and are 
responsible for the biosynthesis of Fe/S proteins in basal and stressed conditions, 
respectively (Xu & Møller, 2011). The mitochondria and plastids of eukaryotes have 
inherited the ISC and SUF systems, respectively, from ancient symbionts (Balk & Lobréaux, 
2005; Balk & Pilon, 2011; Xu & Møller, 2011). Additionally, maturation of Fe/S cluster 
proteins in eukaryotes can be accomplished in the cytosol by a specific set of proteins that 
constitute the cytosolic iron sulfur cluster assembly (CIA) machinery. In this section we will 
summarize the most relevant aspects of the mitochondrial machinery related to the bacterial 
ISC system, and will introduce the limited information available for the CIA system. Most of 
the reports published stem from studies with the budding yeast Saccharomyces cerevisiae, and 
we will refer to them before describing what is known for Fe/S protein biogenesis in 
trypanosomes (Section 3.3.2).  
The building blocks for the biosynthesis of Fe/S clusters are: iron atoms (in the reduced 
form, Fe2+), sulfide (S2-), reducing power and proteins, which act as scaffolds to assemble the 
Fe/S cluster that is being formed (Py & Barras, 2010; Lill & Mühlenhoff, 2006). Sulfide is 
generated from cysteine by the pyridoxal-5-phosphate-dependent cysteine desulfurase 
(eukaryotic Nfs1 or the bacterial NifS, IscS and SufS). This reaction produces alanine and 
leaves a protein-bound cysteine persulfide intermediate, which is presumably reduced by 
the ferredoxin system (NADPH-dependent ferredoxin reductase and ferredoxin) leading to 
release of S2-. Ferredoxin is a Fe/S protein that in mammals is also known as adrenodoxin, 
an essential component of the thyroid hormone production. Recent studies identified an 
accessory protein, Isd11, that is essential for in vivo Fe/S biogenesis in eukaryotes (Adam et 
al., 2006; Shi et al., 2009; Wiedemann et al., 2006). Isd11 forms a tight complex with Nfs1 that 
renders the cysteine desulfurase active (Xu & Møller, 2011). The iron-carrying protein Yfh1, 
known in humans as frataxin or CyaY in bacteria, participates in the delivery of iron for 
Fe/S cluster biosynthesis but whether this protein is or not the direct iron-carrier is still a 
matter of debate. Frataxin dysfunction is responsible for the most common form of inherited 
ataxia in humans, namely “Friederich ataxia” (Py & Barras, 2010; Lill & Mühlenhoff., 2006, 
2008; Stemmler et al. 2010). The next step involves the transient assembly of the newly 
synthesized Fe/S cluster into “scaffold” proteins. These macromolecules are ubiquitous to 
most living organisms and contain conserved cysteine residues that bind Fe/S clusters in a 
labile manner, allowing the complex to be readily transferred to target proteins. The most 
conserved ones are the U-type scaffold proteins (e.g., bacterial IscU and SufU and eukaryotic 
Isu1), and other include the bacterial NifU, plastid NFU and the A-type scaffolds (e.g., IscA 
and SufA; Lill, 2009; Xu & Møller, 2011), which are supposed to work downstream the U-
type ones or to subrogate their function in specific situations (e.g., heme biosynthesis in 
mammals; Ye & Rouault, 2010b). Whereas the mitochondrial ISC system has more than 15 
proteins identified (Lill & Mühlenhoff, 2008), Nfs1-Ids11, Isu1/Isu2 and Yfh1 are the core 
elements for Fe/S cluster biogenesis in eukaryotic mitochondria (Fig 2; Lill & Mühlenhoff, 
2006).  
The transference of the Fe/S cluster to the target apoprotein is assisted by a set of proteins 
and consumes energy (Amutha et al., 2008; Subramanian et al., 2011). The minimal 
components are: a dedicated chaperone from the HSP70 family termed Ssq1, the DnaJ-like 
chaperon Jac1, the nucleotide exchange factor Mge1 and a mitochondrial monothiol 
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glutaredoxin (Grx5 in humans and yeast; Fig. 2). The requirement for a glutaredoxin-like 
protein, formerly considered an oxidoreductase (Lillig et al., 2008; Rouhier et al., 2010), in 
Fe/S cluster biogenesis was initially suggested by studies in a yeast Grx5 deletion mutant. 
These cells displayed deficient cluster assembly for at least two Fe/S proteins (aconitase and 
succinate dehydrogenase), leading to impaired respiratory growth and increased sensitivity 
to oxidative stress with accumulation of free iron in the cell (Rodríguez-Manzaneque et al., 
1999 and 2002). Although the precise function of monothiol glutarredoxins within the iron 
metabolism remain to be established, they are critical components of the ISC biosynthetic 
pathway in distantly related organisms such as bacteria (Fernandes et al., 2005), protists 
(Comini et al., 2008) and vertebrates (Xu & Møller, 2011; Ye et al., 2010; Ye & Rouault, 2010b).  
The CIA machinery was first discovered in yeast when seeking for cytosolic proteins 
essential for Fe/S cluster assembly on aconitase (Fig. 2). Nowadays, several components are 
recognized: i) two P-loop NTPases (Cfd1 and Nbp35) that form a stable heterotetrameric 
complex with a [4Fe-4S] cluster bound to the C-terminal region, suggesting a scaffold role 
for cluster assembly; ii) Nar1, a Fe/S-dependent protein related to bacterial iron-containing 
hydrogenases, iii) WD40 ǃ-propeller protein Cia1, which preferentially localizes in the 
nucleus and assists cluster delivery to Nbp35 (Lill & Mühlenhoff, 2008; Sharma et al., 2010; 
Xu & Møller, 2011), and iv) redox components of the CIA machinery (Tah18, Dre2 and 
monothiol glutaredoxins 3 and 4). In yeast, intracellular iron level is sensed by the 
transcription factor Aft1 and requires the regulatory proteins Fra1-Fra2 that interact with the 
cytosolic-nuclear monothiol glutaredoxins Grx3 or Grx4 through the formation of 
heterodimers linked by a Fe/S cluster (Kumánovics et al., 2008; Mühlenhoff et al., 2010; 
Pujol-Carrion et al., 2006). Interestingly, besides the existence of specific and 
compartmentalized machineries, Fe/S cluster biogenesis in the cytosol has been confirmed 
to depend on the mitochondrial system. A still unknown essential compound (noted as “X” 
in Fig. 2) is exported from mitochondria via the inner mitochondrial membrane ATP-
binding cassette (ABC) transporter Atm1 and the intermembrane space protein Erv1, in a 
process that requires GSH (Netz et al., 2010; Sharma et al., 2010; Xu & Møller, 2011). As 
pointed by Ye and Rouault (2010a, 2010b) the next frontier in Fe/S cluster biogenesis will 
consist in unraveling how the monothiol glutaredoxin 5 and ABCB7 transporter are 
involved in the mitochondrial synthesis and export to the cytosol/nucleus of a still 
unknown factor that connects these processes in both compartments. Moreover, it remains 
to be studied how the system operates as a whole (Mühlenhoff et al., 2010; Netz et al., 2010; 
Zhang et al., 2008).  
3.3.2 Biogenesis of iron-sulfur clusters in trypanosomes 
The characterization of the Fe/S biogenesis in trypanosomes was driven by the completion 
of the genome sequencing of three trypanosomatid species (Berriman et al., 2005; El Sayed et 
al., 2005; Ivens et al., 2005). As noted previously, the mitochondrion is a key organelle in 
Fe/S cluster biosynthesis that undergoes important metabolic and morphological changes in 
trypanosomatids, especially in African trypanosomes, during life cycle. For instance, several 
mitochondrial respiratory-chain proteins that depend on these cofactors are 
developmentally synthesized in insect stage parasites (Alfonzo & Lukeš, 2011; Tyler et al, 
1997). Based on sequence comparison with identified Fe/S cluster biogenesis proteins from 
yeast, plants and humans, a number of members of the ISC system are conserved in 
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trypanosomatids (see Fig. 2). Smíd et al. (2006) characterized two major components of this 
machinery present in T. brucei: a cysteine desulfurase (TbIscS2, related to Nfs1) and one U-
type scaffold protein (TbIscU, related to Isu1). Both proteins proved to be essential for the 
mitochondrial biogenesis of Fe/S proteins (Smíd et al., 2006). In agreement with phenotypes 
observed in yeast mutants, down-regulation of TbIscS2 in procyclic parasites by RNAi 
results in inhibition of Fe/S cluster dependent processes both in the mitochondrion and 
cytosol, with a concomitant impairment in ATP production, cellular respiration and growth 
(Smíd et al., 2006; Paris et al., 2009). The occurrence of this protein in the rudimentary 
mitochondrion of bloodstream parasites was still not addressed but appears reasonable 
considering that this stage relies on important Fe/S protein activities (Comini et al., 2008). 
As mentioned above, a stable tricomponent system between Nfs1, Isd11 and IscU have to be 
formed to enable the formation of Fe/S cluster on IscU. An Isd11 homologue is actively 
expressed by both life stages of T. brucei and, as expected, is critical for cytosolic and 
mitochondrial Fe/S cluster biosynthesis in trypanosomes (Paris et al., 2010). A second Nfs-
like gene was identified in T. brucei (Smíd et al., 2006) and characterized as a selenocysteine 
lyase (SLC; Poliak et al., 2010), an enzyme that cleaves selenocysteine into alanine and 
selenium during selenoprotein metabolization. Supporting the experimental evidences on 
the dispensability of the selenoproteome for this parasite (Aeby et al, 2009), down-regulation 
of SLC is not detrimental for T. brucei, at least under cultivation (Poliak et al., 2010). A single-
copy gene with a significant sequence similarity to eukaryotic frataxin was identified in T. 
brucei genome (TbFXN; Long et al., 2008b). Abrogation of frataxin function in the 
mitochondrion of procyclic cells induces a growth-retardation phenotype with a marked 
inhibition of Fe/S-dependent processes, e.g., aconitase activity (Long et al., 2008a, 2008b). 
Interestingly, TbFXN was also identified in the bloodstream form of the parasite but its 
biological relevance was not addressed (Long et al., 2008b). Works with the fission yeast 
indicate that thiolation of tRNA depends on components from the mitochondrial and 
cytosolic ISC systems (Lill & Mühlenhoff, 2006, 2008). A similar link between both pathways 
has recently been disclosed for trypanosomes (Alfonzo & Lukeš, 2011; Bruske et al., 2009). 
More recently, two A-type scaffold proteins from T. brucei were characterized and their 
function rated as essential for the growth and Fe/S cluster metabolism of procyclic but not 
of bloodstream parasites (Long et al., 2011), suggesting specificity for Fe/S protein acceptors 
that are developmentally regulated. The final step in mitochondrial Fe/S cluster biogenesis 
consists in the delivery of the cluster to acceptor proteins, in an ATP-depedent process 
assisted by mitochondrial HSP70 and monothiol glutaredoxins, interestingly, the last being 
Fe/S proteins (Comini et al., 2008; Manta et al., unpublished). Three sequences for putative 
monothiol glutaredoxins, named 1-C-Grx1 to 3, are present in the genome of different 
trypanosomatids (Berriman et al., 2005; El Sayed et al., 2005; Ivens et al., 2005). The proteins 
from T. b. brucei are the best studied so far. 1-C-Grx1 and 1-C-Grx2 localizes at the parasite 
mitochondrion (Filser et al., 2007; Comini et al., 2008; Manta et al. unpublished), whereas 1-C-
Grx3, a hybrid protein containing an N-terminal Trx domain, is probably cytosolic. 1-C-Grx1 
and 1-C-Grx3, but not 1-C-Grx2, are abundant proteins in bloodstream parasites and reach 
maximum levels in stationary phase cultures (Comini et al., 2008). Strikingly, targeting these 
proteins to the mitochondria of S. cerevisiae defective in Grx5 did not rescue the mutant 
phenotype, suggesting the existence of structural or biochemical differences between the 
trypanosomal and eukaryote/prokaryotes orthologues (Filser et al., 2007). Indeed, in vitro all 
three proteins are capable to coordinate an Fe/S cluster at expenses of a protein thiol and 
low molecular mass thiols that are parasite-specific, namely T(SH)2 and 
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monoglutathionilspermidine (Comini et al., 2008; Manta et al. unpublished). We observed a 
similar behavior for T. cruzi 1-C-Grx1 (Fleitas et al., unpublished). 1-C-Grx1 is indispensable 
for infective T. brucei with an important function in parasite iron homeostasis and no role in 
protection against oxidants (Comini et al., 2008; Manta et al., unpublished), as previously 
proposed for yeast Grx5 (Rodriguez-Manzaneque et al., 1999). Overexpression of a 
functional apo-mutant of 1-C-Grx1 impairs parasite survival inside an animal host (Manta et 
al., unpublished). Also overexpression of a wildtype form of 1-C-Grx1 was detrimental for 
parasite survival either in vitro (under iron deprivation or oxidative stress conditions) and in 
vivo (mice), indicating that iron homeostasis in African trypanosomes is tightly controlled 
with this protein playing an important role. Altogether, this provides the first evidence for a 
critical physiological role of iron and Fe/S cluster metabolism for T. brucei survival during 
infection. The information concerning Fe/S cluster biogenesis in the cytosol of 
trypanosomes is very scarce. So far, only a putative orthologue of ABCB7 was identified in 
T. brucei genome (Sauvage et al., 2009) and, as outlined above, the occurrence of a putative 
cytosolic monothiol glutaredoxin orthologue of yeast Grx3/Grx4 was described (Smíd et al., 
2006; Filser et al., 2007; Comini et al., 2008). Further investigations are required to establish 
whether trypanosomal 1-C-Grx3 shares a regulatory function on iron- and iron-sulfur-
homeostasis as their yeast counterparts.  
As noted by Long et al. (2011), following the identification of several components of the ISC 
system in T. brucei and owing to the high degree of evolutionary conservation for this 
important pathway it is reasonable to assume a similar complexity for the Fe/S cluster 
assembly machinery in this unicellular eukaryote with respect to that of yeast or even 
human. Nevertheless, certain structural or biochemical specialization in some of it molecular 
components may be envisaged (Filser et al., 2007; Comini et al., 2008; Manta et al., 
unpublished). The regulation of Fe/S biogenesis in trypanosomes is equally unexplored yet. 
Considering the Fe/S metabolic repertoire of each developmental stage of the parasite, it 
makes sense to consider multiple and inter-dependent mechanisms controlling substrate 
supply, Fe/S-biosynthesis and turnover, all important issues that await elucidation. Another 
challenging question raised by Smíd et al. (2006) deals with the identification of the factor(s) 
triggering Fe/S-cluster and -protein synthesis during differentiation. 
3.3.3 Examples of iron-sulfur proteins in trypanosomes 
3.3.3.1 Aconitase 
The enzyme aconitase (EC 4.2.1.3) is an essential component of the mitochondrial 
tricarboxylic acid cycle that catalyzes the reversible conversion of citrate to isocitrate 
through the intermediary formation of the tricarboxylic acid cis-aconitate. Aconitase 
contains an [2Fe-2S] center that acts both in substrate binding and catalytic addition or 
removal of H2O, but not in electron transfer reactions. In addition to this enzymatic activity, 
cytosolic isoforms of apo-aconitase participate in regulation of cellular iron homeostasis, 
therefore, receiving also the name of iron-regulatory proteins (IRP). In its apo-form (non-
cluster bound) aconitase undergoes a conformational change that confers the protein with 
affinity to bind the 3’- or 5’- untranslated regions, known as IRE (iron-response elements), 
present in the mRNA encoding for several proteins related to iron uptake and 
metabolization. Under iron starvation the ratio apo:holo aconitase increases and, hence, IRP 
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activation takes over the post-translational response that triggers iron mobilization, uptake 
and utilization (Hentze et al., 2010).  
As mentioned previously, the bloodstream form of T. brucei possess a rudimentary 
mitochondrion with most enzymes from the Krebs cycle repressed (Saas et al., 2000). In this 
parasite, aconitase is encoded by a single gene whose sequence resembles that of the 
cytosolic isoform of mammalian aconitase (Fast et al., 1999; Saas et al., 2000). The protein 
localizes within both the cytosol and mitochondrion (Saas et al., 2000). While the mRNA 
abundance is almost unaffected during development, the protein content increases several 
times during transformation from dividing to arrested bloodstream form (Overath et al., 
1986), in concordance with the morphological and biochemical events that occur in the 
preparation of the parasite to differentiate to the insect stage (Saas et al., 2000). The protein is 
not essential for infective or procyclic parasites (van Weelden et al., 2003) neither involved in 
the regulation of the transferrin receptor (Fast et al., 1999), as occurs in mammals. Moreover, 
genome survey indicated the absence of sequences with homology to IREs in trypanosomes 
(Berriman et al., 2005; Ivens et al., 2005; El-Sayed et al., 2005), which in principle agrees with 
the low aconitase activity detected in bloodstream parasites and its dispensability for 
procyclic forms. The discovery that insect stage T. brucei does not rely on Krebs cycle for 
pyruvate metabolisation has set a new metabolic paradigm for this parasite species. Despite 
T. brucei aconitase has never been shown in vitro to be a Fe/S-dependent protein, its high 
sequence conservation (Saas et al., 2000) and several biological data supports its Fe/S nature. 
For instance, knockdown of IscS, IscU (Smíd et al., 2006) and Isd11 (Paris et al., 2010) was 
followed by down-regulation of aconitase activity both in the mitochondria and cystosol. 
The final answer for the physiological (in)dispensability of aconitase in infective parasites 
will have to await experiments in animal infection models.  
3.3.3.2 Fumarate hydratases  
Fumarases, also called fumarate hydratases (FHs, E.C. 4.2.1.2), are ubiquitous enzymes that 
catalyze the stereospecific reversible hydration of fumarate to malate. Most prokaryotes and 
eukaryotes express two isoforms of fumarases. In eukaryotes, the mitochondrial isoform is a 
component of the tricarboxylic acid cycle and, hence, central to aerobic respiration. The 
cytosolic isoform is probably involved in the metabolism of fumarate that stem from a 
number of reactions occurring in the cytosol. Two distinct classes of fumarases, class I and 
class II, have been identified so far. The proteins lack sequence homology but are 
functionally related. Class II fumarases (or fumC enzymes) are iron-independent enzymes. 
They occur in several bacteria and in eukaryotes, such as fungi, mammals, and higher 
plants. In contrast, class I fumarases are Fe/S-containing enzymes. Bacteria but also 
unicellular eukaryotes contain class I fumarases. The characterization of two class I 
fumarases in T. brucei revealed that two single copy genes code for mitochondrial and 
cytosolic isoforms that are expressed in procyclic but not in bloodstream parasites (Coustou 
et al., 2006). Simultaneous downregulation of both transcripts was deleterious for the 
viability of procyclic trypanosomes, a phenotype that was counteracted by the addition of 
extracellular fumarate, highlighting the essential and stage-specific role of this metabolite 
(Coustou et al., 2006). Taking into account that secretion of succinate has been described for 
the infective stage of Leishmania spp. and T. cruzi grown in glucose-supplemented medium 
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(Cazzulo, 1992), the authors proposed the occurrence of FHs in these trypanosomatids. 
Nevertheless, if any, their biochemical importance awaits elucidation. 
4. Heme uptake and utilization  
Heme is an essential cofactor for various proteins. It can perform diverse functions such as 
oxygen transport and storage (hemoglobin and myoglobin), mitochondrial electron 
transport (Complex II–IV), xenobiotic detoxification and steroid metabolism (cytochromes), 
signal transduction (nitric oxide synthases, soluble guanylate cyclases), and regulation of 
antioxidant defense enzymes, since many enzymes like peroxidases, catalases, and the large 
group of cytochrome P450 (CYP450) rely on heme as a prosthetic group. Heme-proteins 
have also been implicated in microRNA processing and microbicide defense (Mochizuki et 
al., 2010; Roberts & Montfort, 2007).  
Heme consists of a cyclic tetrapyrrole ring structure (protoporphyrin IX) that coordinates an 
iron atom which can adopt Fe+3 or Fe+2 oxidation states. Different substitutions over the 
pyrrolic moieties originate the different types of heme (a, b and c; Severance & Hamza, 2009; 
Tripodi et al., 2011). As stated earlier, African trypanosomes are extracellular parasites that 
depend on heme uptake to face their metabolic needs (Fig. 3), thus, the biosynthetic 
pathway operating in the host will be briefly outlined. The complete heme biosynthetic 
pathway involves eight-steps. Although the synthesis of ǅ-aminolevulinic acid (ALA), the 
first heme precursor, may differ between organisms the remaining seven steps of the 
pathway (from ALA to heme b) are strictly conserved. In most heterotrophic eukaryotes the 
biosynthesis alternates between the mitochondria and the cytosol while in photosynthetic 
organisms heme is exclusively produced in the chloroplasts (Korený et al., 2010). Despite its 
essentiality and versatility, iron and porphyrins are highly toxic to cells due to iron-induced 
pro-oxidant effect on DNA, proteins and membrane lipids. Therefore, its biosynthesis and 
storage is tightly regulated in order to reduce the level of free heme inside the cell. 
Certain organisms lack some components of the biosynthetic pathway from ALA to 
protoporphyrin IX and have developed strategies to obtain heme from other sources. The 
tick Boophilus microplus (Braz et al., 1999), the filarial nematode Brugia malayi (Wo et al., 2009), 
the free-living nematode Caenorhabditis elegans (Rao et al., 2005) and most kinetoplastid 
parasites are examples of eukaryotes that are partially or completely unable to synthesize 
heme despite some of their developmental stages depend on oxidative fosforilation (i.e., 
cytochromes) to obtain energy. The order Kinetoplastida contains species where the 
complete biosynthetic pathway is absent (e.g. most members of the genus Trypanosoma), and 
others, such as Leishmania spp. or Crithidia spp., able to perform only the last three 
biosynthetic steps (Chang et al., 1975; Salzman et al., 1982). Although it is very likely that a 
kinetoplastid’s ancestor harbored a complete set of eukaryotic genes for heme synthesis, 
during evolution these genes have been either lost (e.g. Trypanosoma genus) or subsequently 
rescued from a Ǆ-proteobacterium endosymbiont by horizontal gene transfer, as proposed 
for the non-Trypanosoma trypanosomatids (Korený et al., 2010). As a general consequence, 
trypanosomatids must scavenge heme or precursors from their hosts. At this point, it is 
important to note that there are several species of trypanosomatids that parasitize insects, 
including Herpetomonas roitmani, Crithidia deanei, C. desouzai, C. oncopelti and Blastocrithidia 
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Fig. 3. Pathways for heme incorporation and biosynthesis in trypanosomes. 
Although two possible routes for heme internalization have been described in T. cruzi, so far 
none of the putative transporters has been characterized. In T. brucei, hemoglobin (Hb, 
upper left) endocytosis was shown to depend on a haptoglobin-hemoglobin receptor 
(HpHbR) localized at the flagellar pocket (FP) and expressed exclusively in the bloodstream 
form of the parasite. An ABC transporter (ABCG5 in L. major) has been shown to rescue 
heme after lysosomal (L) degradation of Hb. On the other hand, in T. cruzi a non-endocytic 
route was described for free forms of heme (lower part, in green). This is an active process 
mediated by ABC transporters that leads to accumulation of heme inside storage organelles, 
the reservosomes (R). Specific inhibitors for ABC transporters (cyclosporin A, verapamil and 
indomethacin) reduce significantly heme uptake (Peixoto Cupelloa et al., 2011). Intracellular 
parasites endowed with the last three enzymes of heme biosynthesis, such as Leishmania 
spp., are capable to incorporate heme precursors, such as coproporphobilinogen III 
(CPgenIII), which upon transport to the mitochondrial intermembrane space can undergo a 
serie of oxidative reactions leading to the formation of protoporphyrin IX (PPIX) that is 
finally converted into heme by addition of iron through a ferrochelatase (FECH) facing the 
mitochondrial matrix (middle part and insert, orange). Additional subcellular structures and 
biosynthetic components are abbreviated as follows: nucleus (N), kinetoplast (K), 
mitochondrion (M), outer mitochondrial membrane (OMM), inner mitochondrial membrane 
(IMM), coproporphyrinogen oxidase (CPOX), protoporphyrinogen IX (PPgenIX), 
protoporphyrinogen oxidase (PPOX).  
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culicis, which have been found to contain symbiotic bacteria that may supply the protists 
with heme and other essential nutrients (Chang & Trager, 1974). The bacterial symbiotes 
would be subject of regulation by their hosts, hence, functioning as cell organelles rather 
than as independent living entities (Chang et al., 1975).  
Heme’s transport and distribution in trypanosomatids remain elusive. Diffusion across the 
lipid bilayer is hampered for heme due to its anionic carboxylate side-chains. Instead, high 
affinity heme-binding proteins in the cell surface of T. cruzi (Lara et al., 2007), procyclic 
forms of T. brucei (Vanhollebeke et al., 2008) and L. donovani (Campos-Salinas et al., 2011) 
allows for active heme uptake. In T. cruzi epimastigotes, both endocytotic and non-
endocytotic mechanisms of heme internalization have been confirmed. L. donovani can also 
incorporate heme by receptor-mediated endocytosis followed by lysosomal degradation of 
hemoglobin. An ABC transporter localized in membranes of multivesicular structures is 
probably related to intracellular heme trafficking after hemoglobin degradation. Porphyrin 
trafficking in trypanosomatids is yet an uncovered subject but intracellular transport 
appears to involve membrane-bound vesicles as carriers (Severance & Hamza, 1982; Tripodi 
et al., 2011).  
In summary, pathogenic trypanosomatids are auxotrophic for heme and have to adapt their 
heme-dependent metabolic pathways (i.e. biosynthesis of sterols and polyunsaturated fatty 
acids, respiration, oxidative stress response and detoxification) to fluctuations in nutrient 
availability across their life cycle. The most relevant cellular functions requiring heme in 
trypanosomatids are discussed in the next sections.  
4.1 Heme in oxidative defense  
Trypanosomes lack catalase and selenium-dependent glutathione peroxidases but instead 
express two types of trypanothione/tryparedoxin dependent peroxidases to decompose 
endogenous and exogenously produced oxidants (rewieved in Schlecker et al., 2007 and 
Krauth-Siegel & Comini, 2008) and some species have an additional plant-like ascorbate-
dependent hemoperoxidase (APX; Adak & Datta, 2005; Wilkinson et al., 2002a). 
Interestingly, APX is present in intracellular trypanosomatids (T. cruzi and Leishmania spp.) 
but absent in parasites with an extracellular life style in the mammal host, namely T. brucei. 
This feature has been attributed to the major demand for anti-oxidant capacity that 
intracellular parasites need during infection (Wilkinson et al., 2005; Dolai et al., 2009). APX 
localizes to the endoplasmic reticulum (ER; Wilkinson et al., 2002a) and cell membrane (M. 
Hugo et al., personal communication) of T. cruzi and in the intermembrane space of the 
mitochondrial inner membrane in the case of L. major (Dolai et al., 2008). Both enzymes are 
reduced by ascorbate or, alternatively, cytochrome c (Wilkinson et al., 2002a; Dolai et al., 
2008; M. Hugo et al., personal communication). The regeneration of reduced ascorbate 
occurs upon spontaneous reaction of dehydroascorbate with T(SH)2 (Krauth-Siegel & 
Lüdemann, 1996). With respect to the source of ascorbate, in contrast to humans, African 
and American trypanosomes can synthesize this metabolite de novo, a process that takes 
place in the glycosome (Wilkinson et al., 2005). T. cruzi cannot take up ascorbate from the 
environment, as T. brucei does, and therefore relies entirely on its biosynthesis to fuel other 
unknown cellular functions, in addition to oxidant detoxication (Logan et al., 2007). 
The biological role of APX is consistently related to oxidant defense. Overexpression of APX 
in T. cruzi and L. major enhances tolerance against oxidative stress induced by exogenous 
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hydrogen peroxide (Wilkinson et al., 2002a and 2005) and mitochondrial cardiolipin 
oxidation, providing thus protection towards programmed cell death and protein damage 
(Dolai et al., 2008, 2009). This function appears to be redundant with that performed by the 
ER glutathione-like trypanothione-dependent peroxidase of T. cruzi (GPxII; Wilkinson et al., 
2002a) and the mitochondrial trypanothione-dependent peroxiredoxin (mTXNPx) from 
Leishmania spp. However, an explanation for this may lie on different substrate specificities 
(e.g., GpxII reduces fatty acid and phospholipid hydroperoxides; Wilkinson et al., 2002b) or 
the macromolecular targets these enzymes have.  
4.2 Heme in polyunsaturated fatty acids biogenesis 
Fatty acid biosynthesis in trypanosomatids seems to be an essential pathway for the parasite 
life cycle. As stated earlier, differentiation involves dramatic morphological changes in the 
cell and its organelles that certainly require membrane fluidity. The biosynthesis of 
unsaturated fatty acids is another plant-like pathway inherited by trypanosomatids. In this 
respect, lipid desaturation occurs at the methyl end of the molecule, in contrast to mammals, 
in which a double bond is generated at the carboxy end of the molecule.  
T. cruzi and both life stages of T. brucei are able to synthesize fatty acids, although T. brucei 
bloodstream form was formerly thought to depend on lipid uptake from their host. Short 
and medium chain fatty acids are usually synthesized by means of the soluble fatty-acid 
synthetase system and subsequently elongated by the elongase system that resides in the 
ER. T. brucei can elongate fatty acids up to stearate (C18:0). T. cruzi can further elongate C18 
to C24 and C26 fatty acids required in the synthesis of anchors for surface macromolecules. 
The stearate is mainly converted into linoleate (C18:2), which represents near 30% and 40% 
of total fatty acids in T. brucei and T. cruzi, respectively. Moreover, unsaturated fatty acids 
can represent up to 70% of total fatty acid content depending on the parasite species and life 
cycle stage (Alloatti et al., 2010). 
T. brucei oleate desaturase shares high similarity with ∆12 desaturases and, to a lesser extent, 
with ω3 desaturases although the parasite enzyme lacks ω3 desaturase activity. Fatty acid 
desaturases require an electron donor, that can be either ferredoxin in plastids and bacteria 
or cytochrome b5 (cytb5) in the ER, as it is the case for the orthologue from T. brucei (Uttaro, 
2006). Since T. brucei oleate desaturase lacks a consensus sequence for the covalent binding 
of cytb, it has been suggested that electron donation occurs via complex formation with 
another desaturase capable to bind cytb5 (Petrini et al., 2004). The drastic growth defect 
observed upon partial ablation of enzyme activity (even an 8% reduction) by RNAi is a 
strong indication of the essentiality of this pathway for infective parasites (see also section 
3.2.4; Alloatti et al., 2010) 
4.3 Trypanosomes contain unusual single-cys cytochromes 
Cytochromes are heme-containing complexes that participate in many electron transfer 
reactions including oxidative phosphorylation in the respiratory chain (cytochromes type c, 
cytc and cytochromes type c1, cytc1), desaturation of fatty acids or xenobiotic detoxification 
(Comini et al., 2011). In cytc heme is covalently attached through thioether bonds between 
the vinyl groups of the heme and the thiols of two cysteine residues in a conserved CXXCH 
motif, in which the histidine functions as an axial ligand for heme iron. Mitochondrial cyt c 
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is the best known example of this type of protein. It is located in the intermembrane space 
and transfers electrons from the cytochrome bc1 complex to the cytochrome aa3 oxidase. 
Cytochrome c1 of the bc1 complex (cytochrome reductase) is also a c-type cytochrome. Heme 
coordination by cytc and cytc1 from euglenoids (e.g. the green flagellated algae Euglena 
gracilis) and trypanosomatids occurs through a single thioether bond involving the single 
thiol group from their binding motifs AAQCH and FAPCH, respectively (Priest & Hajduk, 
1994). As another example of a metabolic trait that trypanosomatids share with higher 
plants, plastids contain b6f-type cytochromes with heme covalently attached through a 
single thioether bond (Allen et al., 2004; Tripodi et al., 2011). The biogenesis of holo 
cytochrome c is a catalyzed process that involves different mechanisms and enzymatic 
components that can be grouped into five major systems (Tripodi et al., 2011). The 
cytochrome c maturation machinery employed by kinetoplatids remains unidentified and is 
possibly unique to this and the entire euglenid taxon (Allen et al., 2004; Tripodi et al., 2011). 
Based on the metabolic repertoire of each developmental stage, the relevance of cytochrome 
activity for energy production appears to be restricted to the procyclic form of the parasite.  
4.4 Heme in sterol biogenesis 
Cholesterol, ergosterol and sitosterol are essential structural components of plasma 
membranes from mammals, fungi and plants, respectively. They stabilize membranes, 
determine their fluidity and permeability, and modulate the activity of membrane-bound 
enzymes and ion channels. T. cruzi and T. brucei encode all sterol biosynthetic enzymes, 
including sterol 14-ǂ-demethylase (CYP51), a member of the CYP450 superfamily that 
operates at the initial phase (post-squalene stage) of the pathway that drives the oxidative 
removal of the 14-ǂ-methyl group from the newly cyclized sterol precursors. Azole-based 
compounds, common in antifungal therapies (e.g., posaconazole) proved to be potent 
inhibitors of CYP51 by interacting with the enzyme active site and its prosthetic group 
(Chen et al., 2010). Inhibition of CYP51 leads to accumulation of 14ǂ-methylated sterols, 
which are unable to replace ergosterol in the membrane because of steric hindrance, 
followed by growth arrest and cell death (Lepsheva et al., 2007; Vanden Bosschef et al., 1995). 
In contrast to T. cruzi and Leishmania spp., ergosterol has been thought to be dispensable for 
T. brucei. However, the observation that antifungals are also detrimental for this parasite 
lead to the proposal that sterol derivatives may additionally serve as precursors for 
bioactive molecules that act as regulators of cell cycle and development (Lepsheva et al., 
2007).  
Other CYP450s possess a monooxygenase activity that, upon oxygen activation, catalyzes 
the addition of an oxygen atom into an organic substrate and the reduction of the second 
one to water. After each catalytic cycle, CYPs must be restored to their reduced state by a 
CYP450 reductase (CPR), a NADPH-dependant diflavin (FAD/FMN) enzyme that couple a 
two-electron donor (NADPH) with one-electron acceptors, supplying the electrons one at a 
time. CYPs and CPR are involved in the metabolism of a wide range of endogenous 
compounds and xenobiotics including fatty acids, steroids, drugs, alkanes, polycyclic 
hydrocarbons, insecticides and other environmental contaminants (Murataliev et al., 2004). 
In mammals, there is only one CPR gene. However, T. cruzi and L. major encode three 
different CPR genes (CPR-A, CPR-B and CPR-C), while T. brucei possesses four sequences, 
all of them sharing a high sequence identity. Similar to some higher plant species 
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(Koopmann & Hahlbrock, 1997; Ro et al., 2002; Urban et al., 1997), T. cruzi CPRs are encoded 
by a small gene family, with differential regulation and subcellular localization (Portal et al., 
2008). TcCPR-B is localized mainly in reservosomes, TcCPR-C is mostly found in the ER 
while TcCPR-A displays a more ubiquitous distribution pattern (De Vas et al., 2011). The 
presence of multiple isoforms argues for a well-supported P450-mediated molecular system. 
Portal et al. (2008) showed that CPR-B overexpression in T. cruzi confers increased resistance 
to nifurtimox and, more significantly, to benznidazole. In addition, increased levels of CPRs 
are observed in trypomastigotes, a stage that is particularly exposed to stress during cell 
invasion  supporting a role for CPRs in oxidative stress defense (Portal et al., 2008). 
Moreover, CPR-B and CPR-C overexpression increases the synthesis of ergosterol, with the 
concomitant augmentation in membrane rigidity and decrease in endocytic activity. 
Modification in cell membrane fluidity could result in alteration of drug uptake and, as a 
consequence, in the observed drug resistance (De Vas et al., 2011).  
5. Iron and infection 
As noted in the introductory section, African trypanosomiasis is a parasitic disease of 
medical and veterinary importance that has adverse impact in the health and economical 
development of the sub-Saharian region of Africa (Maudlin, 2006; Stijlemans et al., 2008, 
2010a). Since African trypanosomes multiply predominantly in the bloodstream as extra-
cellular parasites, they are continuously dependent on host nutrient supply and exposed to 
host immune attack. As will be addressed next, the response mounted by the mammalian 
host towards infection includes the activation of both arms of the immune system.  
Beyond the aforementioned clinical outcomes for HAT (Section 1), the most prominent 
immunopathological disease-related feature of trypanosomiasis is anemia. In fact, anemia is 
the major cause of death in bovine trypanosomiasis and an important debilitating symptom 
in HAT (Stijlemans et al., 2008). Anemia of inflammation, also termed anemia of chronic 
disease (ACD), is frequent among patients suffering chronic inflammatory disorders (e. g., 
autoimmune diseases) or chronic infections (Camaschella & Strati, 2010). ACD is the 
consequence of a persistent activated inflammatory immune response and is considered to 
be a defense mechanism where the host establishes an iron “withholding” strategy to limit 
the availability of essential iron for the pathogens (Lalonde & Holbein, 1984; Stijlemans et al., 
2008; Sutak et al., 2008). Stijlemans and coworkers (Stijlemans et al., 2008, 2010a, 2010b; 
Vankrunkelsven et al., 2010) studied the immunological and hematological development of 
T. brucei infection using animal models (cattle and mice). Despite mouse models show 
limitations and artifacts, like the extremely high parasitemia levels reached compared to 
infection in the natural host, they have contributed significantly to our current 
understanding of trypanosomiasis patho-physiology (Magez & Caljon, 2011). The molecular 
mechanism underlying the development of ACD during trypanosomiasis resembles that 
observed in other infectious diseases. Briefly, during the early stage of the infection 
trypanosomes stimulate T-cells to secrete interferon-Ǆ resulting in the activation of 
macrophages (type I cellular immune response) that liberate pro-inflammatory mediators 
like tumor necrosis factor, interleukin (IL) -1, IL-6 and NO (Stijlemans et al., 2010b). This 
response leads to parasite clearance but also enhances erythrophagocytosis by activated 
macrophages within the spleen and liver (Kupffer cells). At this point it is important to 
recall that under physiological conditions Kupffer cells recycle iron from engulfed senescent 
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erythrocytes (see Section 2; Hentze et al., 2010). Thus, enhanced removal of red blood cells 
from systemic fluids by the reticuloendothelial system will contribute to deprive host of 
iron. In addition, hepcidin (Section 2) is secreted in response to pro-inflammatory mediators, 
blocking iron release from macrophages and iron intake by enterocytes (Nishimura et al., 
2011), which decreases plasma iron levels and limits host and pathogen accessibility to the 
metal (Taylor & Kelly, 2010). The upregulation of several iron-related molecules (e.g. 
hemooxygenase 1, ferritin and ferroportin) provides additional evidence for the strong type 
I immune response, augmented liver iron-metabolism and accelerated senescence of 
erythrocytes that takes place during trypanosomal infection (Nishimura et al., 2011; 
Omotainse & Anosa, 1992; Stijlemans et al., 2010a; see Section 2). The class of anemia 
originated during the acute phase of trypanosomiasis is a typical non-haematopoietic 
anemia. However, if at the long term the type I response persists, then iron will be 
sequestered intracellularly, resulting in a marked iron deprivation with compromise of 
erythropoiesis and development of ACD (Mwangi et al., 1995; Omotainse & Anosa, 1992; 
Stijlemans et al., 2010b). Despite its adverse effects, if sustained on time, limited iron 
bioavailability can be considered a reasonable host response to control parasitemia (Ganz, 
2009). In the last years, several evidences point to the possibility that the parasite 
deliberately manipulates the mammalian host immune response. Activation of a strong type 
I immune response in early stages of the infection promotes erythrophagocytosis (Igbokwe 
et al., 1994), a strategy that yields abundant iron and lipids (e.g. myristic acid), the last 
needed for GPI biosynthesis and VSG coating (Stijlemans et al., 2010a, 2010b). It is important 
to stress that the trypanosome body is totally covered by a dense GPI-anchored coat of VSGs 
that plays an important protective (physical and immunological barrier) function in 
bloodstream parasites (Comini et al., 2011).  
A large number of microbial pathogens have been reported to affect the morbidity and 
mortality of patients with high iron content, a physiopathological state characterized by the 
presence of non-transferrin bound iron in plasma. Moreover, iron overload due to genetic 
predisposition, therapeutic intervention or nutritional status is known to increase the risk of 
several infections (Kontoghiorghes et al., 2010). It is worth to note that human iron overload 
is common in rural populations inhabiting sub-Saharan regions of Africa, the “tsetse belt”, 
with a high incidence of HAT (Gordeuk, 2002; McNamara et al., 1999). Originally, this 
chronic condition was supposed to be an exclusive consequence of an iron-rich diet based 
on the large consumption of homebrewed beers, but recent studies of pedigrees suggest the 
presence of genetic components (Gordeuk, 2002; Moyo et al., 1998). It remains to be 
investigated whether there is a co-evolutionary development of iron overload and HAT, as 
it is the case for glucose-6-phosphate dehydrogenase deficiency and malaria.  
Considering the well-known role of iron in T. brucei infection and the fact that in vitro iron 
deprivation with chelating agents cause growth retardation of bloodstream T. brucei (Fast et 
al., 1999; Breidbach et al., 2002; Comini et al., 2008), it is surprising the absence of works 
studying the therapeutic potential of iron chelation against T. brucei (Tayor & Kelly, 2010). 
This is not the case for T. cruzi, for which the chelating agent deferoxamine (DFX) proved its 
efficacy to halt replication of intra-macrophage amastigotes (Arantes et al., 2011; Lalonde & 
Holbein, 1984; Jones et al., 1996), and to decrease parasitemia and mortality of infected mice 
(Loo & Lalonde, 1984). However, in contrast to extracellular T. brucei, the possible success of 
chelating therapies against T. cruzi infection are hampered by the intracellular nature of the 
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infective stage of this parasite, which, if not specifically targeted to the pathogen, will imply 
a high dosage or a long-term treatment, both deleterious for the host. Based on the 
demonstration that iron metabolism is crucial for parasite survival in the host (Manta et al., 
unpublished; see section 3.3.2), our group has recently evaluated the therapeutic effect of 
intraperitoneal (i.p.) and oral administration of DFX to T. brucei infected mice. Preliminary 
results show a marked increase in life span of the animal group receiving i.p. treatment (200 
mg/Kg for ~10 days) and almost no side effects (red blood cell and reticulocyte counts) on 
animals treated but non-infected (Manta et al., unpublished). However, DFX displayed a 
cytostatic effect against acute infection by T. brucei, which implies that a successful 
therapeutic regimen will require drug association.  
6. Summary and outlook 
As any other living organism on earth, trypanosomes depend on iron to fulfill critical 
cellular functions (DNA and lipid biosynthesis, oxidant protection and energy generation). 
Their complex life cycle has added an additional problem in the struggle for the supply of 
(micro)nutrients. However, these organisms have developed different strategies and 
mechanisms in order to ensure a physiological iron status within the distinct hosts. 
Moreover, host-parasite co-evolution has resulted in the development of well-balanced 
growth regulation systems, allowing the parasite to survive sufficiently long without killing 
its mammalian host and ensuring an efficient transmission cycle. Interruption of this cycle is 
necessary to abolish the devastating disease these parasites produce to humans and 
livestock. In this respect, the iron metabolism of trypanosomatids should be considered as a 
promising target for effective antiparasitic treatments. Although metal-chelating 
compounds are, obviously, not innocuous to the host, in general they are less toxic than the 
drugs actually used for the treatment of HAT and their side effect is fully reversible upon 
dietary supplementation. In addition, several chelating agents are approved for the 
treatment of human pathologies, some of them are relatively cheap and available for oral 
administration (Sharma & Pancholi, 2010). The risk/benefit assessment for the use of iron 
chelating drugs as antiparasitic therapeutic depends on many factors not addressed yet.  
Moreover, beyond the relevance of iron homeostasis for parasite survival, some components 
of this metabolism and/or iron-, Fe/S cluster- or heme-proteins offer excellent opportunities 
for the design of more specific and efficacious drugs. For instance, the enzymes involved in 
fatty acids biogenesis (oleate desaturase and stearoyl-CoA-desaturase) and sterol 
biosynthesis (CYP51); in defense against oxidants (the plant-like ascorbate peroxidase) and 
xenobiotics (CYP450 reductases); in cell proliferation (ribonucleotide reductase); and in Fe/S 
cluster biogenesis. Alternatively, chemical downregulation of the functions these proteins 
fulfill in the cell can be complemented by the action of first line drugs currently used in 
chemotherapy. A combined therapy would have the advantage of reducing dosage, 
shortening treatment and loweing the possibility for development of drug resistance. The 
specificity of the transferrin receptor is another target to be exploited as an efficient 
mechanism to deliver toxic molecules inside the parasite  
The future prospects look promising in terms of finding novel therapeutic options to fight 
trypanosomiasis. However as depicted in Fig. 2 and Fig. 3, there are still several open 
questions that deserve to be investigated in detail to disclose atomic and functional 
divergences within the components of the parasite and host iron metabolism that can lead to 
the development of safer and efficacious drugs. 
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